ETC
CMPX icon

Exchange Traded Concepts’s Compass Therapeutics CMPX Stock Holding History

Exchange Traded Concepts’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,207
Closed -$103K – 1425
2025
Q1 		$103K Sell
54,207
-43,724
-45% -$116K ﹤0.01% 1152
2024
Q4 		$142K Hold
97,931
– – ﹤0.01% 1072
2024
Q3 		$180K Sell
97,931
-14,089
-13% -$17.6K ﹤0.01% 993
2024
Q2 		$112K Sell
112,020
-34,854
-24% -$50.9K ﹤0.01% 934
2024
Q1 		$291K Buy
146,874
+81,055
+123% +$140K 0.01% 807
2023
Q4 		$103K Buy
65,819
+16,690
+34% +$28.9K ﹤0.01% 882
2023
Q3 		$96.8K Buy
49,129
+5,924
+14% +$14.6K ﹤0.01% 907
2023
Q2 		$137K Buy
+43,205
New +$136K ﹤0.01% 868

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Exchange Traded Concepts's CMPX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Compass Therapeutics (CMPX) in Q2 2025, closing a stake of 54,207 shares — an estimated $103K sold.

Exchange Traded Concepts first reported a position in CMPX in Q2 2023 and held it in 8 quarters. The position peaked at $291K in Q1 2024. 103 funds tracked by Wall St. Rank hold CMPX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Compass Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 54,207 Compass Therapeutics shares in Q2 2025, an estimated $103K.
  • Exchange Traded Concepts first reported a position in Compass Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Compass Therapeutics position peaked at $291K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.